Advanced Biomed (ADVB) Total Liabilities (2023 - 2026)

Advanced Biomed has disclosed Total Liabilities across 4 years of filings, most recently posting $1.4 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.4 million, down 65.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 65.45% YoY), and the FY2025 annual result was $10.2 million, up 266.11% from the prior year.
• Total Liabilities came in at $1.4 million for Q1 2026 at Advanced Biomed, up from $1.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $10.2 million in Q2 2025 to a low of -$1.1 million in Q3 2024.
• The 4-year median for Total Liabilities is $2.1 million (2024), against an average of $2.6 million.
• Across the five-year window, Total Liabilities soared 2073.74% in 2024 and slumped 65.45% in 2026, its largest moves.
• Advanced Biomed's Total Liabilities stood at -$196841.0 in 2023, then jumped by 2073.74% to $3.9 million in 2024, then slumped by 64.76% to $1.4 million in 2025, then increased by 4.93% to $1.4 million in 2026.
• The last three Total Liabilities figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.